Stock UniverseDerived research view · source repositories remain read-only

Exact Sciences Corporation (EXAS)

Life Science Tools / Diagnostics / MedTech · Healthcare / Diagnostics & Research
Score Band
High
Selection Score
42.17
Global Rank
224
Market Cap
19.73B
Latest Close
n/a
RS Composite
n/a

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
Return
n/a

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: n/a · 30-day average: n/a · Max drawdown over stored range: n/a

Research Snapshot

Relative Strength vs SPX

No RS data available.

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank21 / 246
Primary Percentile91.87
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 6/30/20202020-07-311.13Bn/a-281.15M-154.35Mn/a-221.53M217.94M-439.48M0Mn/a-24.86%-13.65%-19.59%-38.85%1.22Bn/a

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 6/30/2020n/an/an/an/an/an/an/an/a

Shares Diluted: 0M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue1767.0872084.2792499.7662758.8673246.99
Revenue Growth (YoY)18.486%17.95%19.934%10.365%17.693%
Gross Profit1308.331422.9181762.2021918.7172262.839
Operating Income-710.568-634.159-308.835-191.788-150.123
Free Cash Flow-238.002-438.02131.92974.547356.782
Free Cash Flow Per Share-1.389-2.4840.1770.4051.891
EPS (Diluted) GAAP-3.476112-3.54-1.133254-5.585633-1.102078
EPS Growth
EPS Non-GAAP
Gross Margin74.039%68.269%70.495%69.547%69.69%
Operating Margin-40.211%-30.426%-12.355%-6.952%-4.623%
Profit Margin-33.707%-29.915%-8.167%-37.293%-6.404%
Free Cash Flow Margin-13.469%-21.015%1.277%2.702%10.988%
Shares Outstanding (Diluted)171.348176.351180.144184.197188.688
Shares Change (YoY)13.373%2.92%2.151%2.25%2.438%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2020 Q22020-07-31268.87Mn/a-67.01M-24.92%-86.14M-32.04%n/an/a1.22Bn/aprocessed
2025 Q42026-02-13878.38M70.11%-82.59M-9.40%-85.95M-9.79%-0.45189.75M964.71M50.00Mprocessed
2025 Q32025-11-03850.74M68.64%-25.55M-3.00%-19.59M-2.30%-0.10189.26M1.00Bn/aprocessed
2025 Q22025-08-06811.09M69.35%-2.15M-0.26%-1.19M-0.15%-0.01188.90M858.43Mn/aprocessed
2025 Q12025-05-01706.78M70.82%-96.01M-13.58%-101.22M-14.32%-0.54186.81M786.17Mn/aprocessed
2024 Q42025-02-19713.42Mn/a-876.35M-1.23%-864.59M-1.21%-4.67185.32M1.04B50.00Mprocessed
2024 Q32024-11-05708.65Mn/a-39.40M-5.56%-38.24M-5.40%-0.21184.79M1.02B50.00Mprocessed
2024 Q22024-07-31699.26Mn/a-26.26M-3.75%-15.81M-2.26%-0.09184.31M946.78M50.00Mprocessed
2024 Q12024-05-08637.52Mn/a-106.69M-16.74%-110.23M-17.29%n/an/a652.09M50.00Mprocessed
2023 Q12023-11-01628.34Mn/a6.85M1.09%794.00K0.13%0.00184.07M734.41M50.00Mprocessed
2023 Q12023-08-01622.09Mn/a-76.93M-12.37%-81.03M-13.02%-0.45180.20M775.71M50.00Mprocessed
2023 Q12023-05-09602.45Mn/a-77.09M-12.80%-74.15M-12.31%-0.42178.57M698.65M50.00Mprocessed
2022 Q32022-11-03523.07Mn/a-138.06M-26.39%-148.76M-28.44%-0.84177.00M669.11M50.00Mprocessed
2022 Q22022-08-02521.64Mn/a-159.58M-30.59%-166.06M-31.83%-0.94176.36M728.04M50.00Mprocessed
2022 Q12022-04-26486.57Mn/a-176.99M-36.37%-180.94M-37.19%-1.04174.42M816.98Mn/aprocessed
2021 Q42023-02-21791.00Mn/a40.72M5.15%-248.49M-31.41%-1.29192.47M632.06M50.00Mprocessed
2021 Q32021-11-02456.38Mn/a-162.02M-35.50%-166.94M-36.58%-0.97171.98M1.22Bn/aprocessed
2021 Q22021-07-28434.82Mn/a-171.66M-39.48%-176.91M-40.69%-1.03171.49M1.31Bn/aprocessed
2021 Q12021-05-04402.08Mn/a-300.54M-74.75%-31.16M-7.75%-0.20n/a1.38Bn/aprocessed
2020 Q42021-02-16466.34Mn/a-415.30M-89.06%-436.81M-93.67%n/an/a1.84B23.75Mprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.